Atlas Trials

Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis

Clinical trial NCT02737202 · TERMINATED

Trial details

NCT number
NCT02737202
Sponsor
Baylor College of Medicine
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Pulmonary Lymphangioleiomyomatosis
Start date
2016-04-01
Primary completion
2019-07-30
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.